The four trading sessions had close to 90 changes to director interests and substantial shareholdings filed for nearly 50 primary-listed stocks.
Directors or chief executive officers filed 19 acquisitions and four disposals, while substantial shareholders filed six acquisitions and four disposals.
1.Grand Bank Yachts
Willimbury, a private company incorporated in Australia, increased its substantial shareholding in $Grand Banks(G50.SI)$ above the 15% threshold on Mar 28.
The married deal involved 1,709,500 shares being acquired at S$0.31 apiece, boosting the company’s direct interest to 15.79% from 14.86%. It had raised its direct interest above the 14% threshold in June 2022, with that acquisition also transacted at an average price of S$0.31 per share.
2.Huationg Global
On Apr 1, $Huationg Global(41B.SI)$ CEO and executive director Patrick Ng Kian Ann acquired 12.5 million shares in a married deal at S$0.142 per share. With a consideration of nearly S$1.8 million, this increased his direct interest in the civil engineering services provider to 7.75%, from 0.69%.
Mehta Vimesh Piyush was on the other side of the married deal, with his direct interest in the Catalist-listed company reduced to 0.96% from 8.1%. His previous acquisition was on Aug 31, 2023, with 200,000 shares acquired at an average price of S$0.131 apiece.
Ng also maintained a 68.7% deemed interest in Huationg Global by virtue of his 25% shareholding interest in Dandelion Capital, which is the immediate and ultimate holding company of Huationg. The acquisition brings his total interest in the Catalist-listed company to 76.45%.
3.Manulife US Reit
On Apr 4, Manulife US Real Estate Management independent non-executive director Francis Koh Cher Chiew acquired 400,000 units of $ManulifeReit USD(BTOU.SI)$ at US$0.0755 per unit.
This increased his direct interest in the Reit to 450,000 units, or 0.025%.
4.Hyphens Pharma International
On Apr 1, $Hyphens Pharma(1J5.SI)$ non-executive director Tan Kia King acquired 32,000 shares at S$0.275 per share.This increased his total interest in the Catalist-listed company marginally to 28.02% from 28.01%.
Dr Tan has more than 25 years of experience as a medical doctor, starting his career as a medical officer in the Ministry of Health. He was also the managing director of Westpoint Family Hospital, where he was responsible for overseeing the day-to-day operations.
https://www.sgx.com/research-education/market-updates/20240408-huationg-global-ceo-increases-interest-775
Comments